Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets

This is a Phase 2, randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of icovamenib in participants with Type 2 Diabetes who are not achieving glycemic targets despite antihyperglycemic medications.

Participants needed: 60
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Biomea Fusion Inc.Updated: Aug 7, 2026Locations: 18
Eligibility criteria

Males or females, age ≥18 years and ≤75 years [+6]

Have type 1 diabetes mellitus or a secondary form of diabetes [+8]

Status: Recruiting

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

This is a phase 2 randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of icovamenib in participants with Type 2 Diabetes (T2D) not achieving glycemic targets despite Ozempic-based therapy.

Participants needed: 60
Trial details
Phase: Phase 2Age: 18-70Biological sex: AllType: InterventionalSponsor: Biomea Fusion Inc.Updated: Jun 15, 2026Locations: 17
Eligibility criteria

Males or females, age ≥18 years and ≤70 years [+8]

Have type 1 diabetes mellitus or a secondary form of diabetes [+5]